What is CVS's current stock price?

As of now, CVS is trading at $81.97, with a daily change of +1.11%.

What are the risks associated with CVS stock?

CVS Key risk is its Low Risk Level, .

What is CVS next earnings date?

CVS next earnings report is scheduled for Oct 29, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CVS Stock Analysis & IQ Rating | CVS Health

CVS

CVS Health

$81.97

+$0.90 | +1.11%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 83.52

MKT CAP

$ 103.94B

52W Low

$ 43.56

VOL

$ 3.49M

P/E Ratio

22.87

AVG VOL

$ 7.13M

RSI

68.72

TREND

Uptrend

CVS Stock IQ

Login to see CVS Health (CVS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CVS Target Price

Login to display

Strengths

CVS Rewards

Earnings are forecast to grow

CVS Rewards

Trading below its fair value

CVS Rewards

Upgraded on attractively valued

CVS Rewards

Investors confidence is positive

Risk Analysis

CVS Risk Analysis

Possible liquidity concerns

Chart

$75.77 (+8.18%)

$63.21 (+29.68%)

$63.59 (+28.90%)

$61.61 (+33.05%)

1year

6month

3month

1month

CVS Risk Level

CVS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

CVS Analysts Opinion

CVS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CVS Analysts Opinion

CVS Analysts opinion is positive but there was a setback from the past 3 months

CVS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

91%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

75%

100%

CVS Street Opinion

CVS Street view is extremely bullish and have positive views on the near-term outlook

CVS Performance Sentiment

Sentiments overview associated with CVS events and the stock performance.

91%

3%

Positive

Negative

31 out of 34
events present

1 out of 34
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$80.61

Resistance
Price

$73.13

Current Price Range

$83.04

Show methods +

CVS Earnings

The TTM reflects 12-month period, providing review of CVS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

386,641

372,809

357,776

+3.96%

Cost of Revenue

333,195

321,408

303,345

+4.80%

Gross Profit

53,446

51,401

54,431

-0.91%

Operating Exp

43,212

41,606

39,832

+4.16%

Operating Inc

10,234

9,795

14,599

-16.27%

Net Interest Inc

-3,058

-2,958

-2,658

-

Interest Exp

3,058

2,958

2,658

+7.26%

Other Inc Exp

-681

-689

-768

-

EPS Growth

3.60

3.67

6.49

-25.52%

CVS Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.57

Next Earnings Date: Oct 29, 2025

CVS Latest Analysis +

Countdown to CVS Health (CVS) Q3 Earnings: Wall Street Forecasts for Key Metrics. Looking beyond Wall Streets top-and-bottom-line estimate forecasts for CVS Health (CVS) delve into some of its key metrics to gain a deeper insight into the companys potential performance for the quarter ended September 2025.

Today

$81.94 | +1.12%

Potential

CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors. In the latest trading session CVS Health (CVS) closed at $81.07 marking a -1.15% move from the previous day.

Thu Oct 23, 2025

$81.07 | -0.37%

Activity

Momentum

Why CVS Health (CVS) is a Top Value Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Thu Oct 23, 2025

$81.07 | -0.37%

Potential

Ex-Dividend Reminder: Thor Industries CVS Health and Dynex Capital . Looking at the universe of stocks we cover at Dividend Channel on 10/23/25 Thor Industries Inc. (Symbol: THO) CVS Health Corporation (Symbol: CVS) and Dynex Capital Inc (Symbol: DX) will all trade ex-dividend for their respective upcoming dividends. Thor Industries Inc. wi

Tue Oct 21, 2025

$83.04 | +0.68%

Activity

EMD Serono CVS Health To Partner On TrumpRx Fertility Program Launching In 2026. On Thursday President to bring American drug prices in line with the lowest paid by other developed nations known as the most-favored-nation or MFN price.The agreement is with ) (OTC:) for its fertility treatments resulting in substantial cost savings on fertility treatments including:GONAL-F a commonly used fertility medication will be made available to women purchasing directly from TrumpRx.gov at a discount equa

Fri Oct 17, 2025

$82.52 | +1.41%

Activity

Potential

CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading United States Pharmacy and Healthcare. CVS Health Corporation (NYSE:CVS) is included among the 12 Must-Buy Dividend Stocks to Invest in. CVS Health Corporation (NYSE:CVS) st⁠ands among the larg‍est pharmacy and retail chains in the United States w⁠i‍th a n⁠etwork of over 9000 pharmacies and⁠ more th‌a‌n 1000 walk-in clinics. The compa‍nys stoc⁠k has per‍formed strongly th‍is year‍ cl‌imbi‌ng 33% in [….]

Fri Oct 17, 2025

$82.52 | +1.41%

Activity

Potential

Heres Why CVS Health (CVS) is a Strong Momentum Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Thu Oct 16, 2025

$81.37 | +0.84%

Momentum

Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?. CVS Health prepares Q3 results with pharmacy performance and Aetnas progress in focus for investors.

Thu Oct 16, 2025

$81.37 | +0.84%

Activity

Potential

Cantor Fitzgerald Reaffirms Overweight Rating on CVS Health (CVS). CVS Health Corporation (NYSE:CVS) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. CVS Health Corporation (NYSE:CVS) a⁠n American multinational healthcar‍e⁠ comp⁠any received renewed con⁠fidenc‍e from C⁠antor Fitz⁠gerald on⁠ October 10 as‍ the firm reaf⁠firmed its Overwei‍ght rating on the stock. The stock has surged by over 80% since the start of [….]

Thu Oct 16, 2025

$81.37 | +0.84%

Momentum

Potential

Zacks.com featured highlights include StoneCo PagSeguro Digital KT Arrow Electronics and CVS Health. Zacks spotlights StoneCo PagSeguro Digital KT Arrow Electronics and CVS Health as attractive low price-to-book stocks with strong growth prospects.

Thu Oct 16, 2025

$81.37 | +0.84%

Potential

FAQ About CVS Stock Insights

What is CVS current stock price?

What are CVS stock strengths?

What risks are associated with CVS stock?

When is CVS next earnings report?

What is CVS market cap and volume?

What is CVS's current Stock IQ?

Should I buy CVS stock right now?

Is CVS a Strong Buy right now?

What does a 'Strong Buy' rating mean for CVS?

What does a 'Strong Sell' rating mean for CVS?

What factors influence CVS's Stock IQ?

Explore our CVS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CVS Stock Strategies
Effective Risk Management

FIND US ON

Receive our CVS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CVS

CVS Health

Current Price

$81.97

+$0.90 | +1.11%

52W High

$ 83.52

MKT CAP

$ 103.94B

52W Low

$ 43.56

VOL

$ 3.49M

P/E Ratio

22.87

AVG VOL

$ 7.13M

RSI

68.72

TREND

Uptrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CVS Rewards

Earnings are forecast to grow

CVS Rewards

Trading below its fair value

CVS Rewards

Upgraded on attractively valued

CVS Rewards

Investors confidence is positive

Risk Analysis

CVS Risk Analysis

Possible liquidity concerns

CVS Stock IQ

Login to unlock CVS Health (CVS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$75.77 (+8.18%)

$63.21 (+29.68%)

$63.59 (+28.90%)

$61.61 (+33.05%)

1year

6month

3month

1month

CVS Analysts Opinion

CVS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CVS Analysts Opinion

CVS Analysts opinion is positive but there was a setback from the past 3 months

CVS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

91%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

75%

100%

CVS Street Opinion

CVS Street view is extremely bullish and have positive views on the near-term outlook

CVS Risk Level

CVS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

LOW

HIGH

CVS Performance Sentiment

Sentiments overview associated with CVS events and the stock performance.

91%

3%

Positive

Negative

31 out of 34
events present

1 out of 34
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$80.61

Resistance
Price

$73.13

Current Price Range

$83.04

Show methods +

CVS Earnings

The TTM data reflects the most recent 12-month period, providing overview of CVS financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

386,641

372,809

357,776

+3.96%

Cost of Revenue

333,195

321,408

303,345

+4.80%

Gross Profit

53,446

51,401

54,431

-0.91%

Operating Exp

43,212

41,606

39,832

+4.16%

Operating Inc

10,234

9,795

14,599

-16.27%

Net Interest Inc

-3,058

-2,958

-2,658

-

Interest Exp

3,058

2,958

2,658

+7.26%

Other Inc Exp

-681

-689

-768

-

EPS Growth

3.60

3.67

6.49

-25.52%

CVS Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.57

Next Earnings Date: Oct 29, 2025

CVS Latest Analysis

Countdown to CVS Health (CVS) Q3 Earnings: Wall Street Forecasts for Key Metrics. Looking beyond Wall Streets top-and-bottom-line estimate forecasts for CVS Health (CVS) delve into some of its key metrics to gain a deeper insight into the companys potential performance for the quarter ended September 2025.

Today

$81.94 | +1.12%

Potential

CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors. In the latest trading session CVS Health (CVS) closed at $81.07 marking a -1.15% move from the previous day.

Thu Oct 23, 2025

$81.07 | -0.37%

Activity

Momentum

Why CVS Health (CVS) is a Top Value Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Thu Oct 23, 2025

$81.07 | -0.37%

Potential

Ex-Dividend Reminder: Thor Industries CVS Health and Dynex Capital . Looking at the universe of stocks we cover at Dividend Channel on 10/23/25 Thor Industries Inc. (Symbol: THO) CVS Health Corporation (Symbol: CVS) and Dynex Capital Inc (Symbol: DX) will all trade ex-dividend for their respective upcoming dividends. Thor Industries Inc. wi

Tue Oct 21, 2025

$83.04 | +0.68%

Activity

EMD Serono CVS Health To Partner On TrumpRx Fertility Program Launching In 2026. On Thursday President to bring American drug prices in line with the lowest paid by other developed nations known as the most-favored-nation or MFN price.The agreement is with ) (OTC:) for its fertility treatments resulting in substantial cost savings on fertility treatments including:GONAL-F a commonly used fertility medication will be made available to women purchasing directly from TrumpRx.gov at a discount equa

Fri Oct 17, 2025

$82.52 | +1.41%

Activity

Potential

CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading United States Pharmacy and Healthcare. CVS Health Corporation (NYSE:CVS) is included among the 12 Must-Buy Dividend Stocks to Invest in. CVS Health Corporation (NYSE:CVS) st⁠ands among the larg‍est pharmacy and retail chains in the United States w⁠i‍th a n⁠etwork of over 9000 pharmacies and⁠ more th‌a‌n 1000 walk-in clinics. The compa‍nys stoc⁠k has per‍formed strongly th‍is year‍ cl‌imbi‌ng 33% in [….]

Fri Oct 17, 2025

$82.52 | +1.41%

Activity

Potential

Heres Why CVS Health (CVS) is a Strong Momentum Stock. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.

Thu Oct 16, 2025

$81.37 | +0.84%

Momentum

Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?. CVS Health prepares Q3 results with pharmacy performance and Aetnas progress in focus for investors.

Thu Oct 16, 2025

$81.37 | +0.84%

Activity

Potential

Cantor Fitzgerald Reaffirms Overweight Rating on CVS Health (CVS). CVS Health Corporation (NYSE:CVS) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. CVS Health Corporation (NYSE:CVS) a⁠n American multinational healthcar‍e⁠ comp⁠any received renewed con⁠fidenc‍e from C⁠antor Fitz⁠gerald on⁠ October 10 as‍ the firm reaf⁠firmed its Overwei‍ght rating on the stock. The stock has surged by over 80% since the start of [….]

Thu Oct 16, 2025

$81.37 | +0.84%

Momentum

Potential

Zacks.com featured highlights include StoneCo PagSeguro Digital KT Arrow Electronics and CVS Health. Zacks spotlights StoneCo PagSeguro Digital KT Arrow Electronics and CVS Health as attractive low price-to-book stocks with strong growth prospects.

Thu Oct 16, 2025

$81.37 | +0.84%

Potential

Discover CVS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CVS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CVS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CVS Stock trends

CVS Stock performance

CVS Stock analysis

CVS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CVS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CVS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CVS Stock Analysis & IQ Rating | CVS Health

CVS Stock IQ

CVS Target Price

CVS Risk Level

CVS Analysts Opinion

CVS Street Consensus

CVS Performance Sentiment

Technical Price Levels

CVS Financial Health

Explore our CVS Stock insights

Receive our CVS Daily Alerts

CVS Stock IQ

CVS Street Consensus

CVS Risk Level

Technical Price Levels

Discover CVS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CVS. We're here to help you make informed investment decisions today.

Receive our CVS Daily Alerts

CVS Runner Alarm